BioCryst Pharmaceuticals
BCRX
#4613
Rank
S$3.15 B
Marketcap
S$12.33
Share price
-1.22%
Change (1 day)
15.86%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -S$0.59 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are S$0.88 Billion. In 2025 the company made an earning of S$0.33 Billion, an increase over its 2024 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.59 Billion-271.67%
2025 S$0.33 B-407.51%
2024 -S$0.12 Billion-61.56%
2023 -S$0.29 Billion-7.43%
2022 -S$0.32 Billion34.42%
2021 -S$0.24 Billion-0.55%
2020 -S$0.24 Billion67.88%
2019 -S$0.14 Billion7.55%
2018 -S$0.13 Billion53.92%
2017 -S$83.61 Million19.29%
2016 -S$70.09 Million28.19%
2015 -S$54.68 Million-4.8%
2014 -S$57.44 Million50.09%
2013 -S$38.27 Million-23.29%
2012 -S$49.89 Million-26.19%
2011 -S$67.59 Million54.78%
2010 -S$43.67 Million150.1%
2009 -S$17.47 Million-49.43%
2008 -S$34.53 Million14.07%
2007 -S$30.27 Million-49.31%
2006 -S$59.72 Million72.87%
2005 -S$34.55 Million22.08%
2004 -S$28.3 Million75.3%
2003 -S$16.15 Million-25.36%
2002 -S$21.63 Million225.05%
2001 -S$6.66 Million-56.6%
2000 -S$15.33 Million50.63%
1999 -S$10.18 Million38.05%
1998 -S$7.38 Million-52.46%
1997 -S$15.51 Million58.44%
1996 -S$9.79 Million-14.44%
1995 -S$11.44 Million28.57%
1994 -S$8.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$13.63 B-2,462.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.72 B-2,304.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$31.09 M-105.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$99.2 M-117.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-S$81.93 Million-85.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.4 Billion-31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.29 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$28.21 Million-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$75.11 M-113.01%๐Ÿ‡บ๐Ÿ‡ธ USA